BioTime appoints Brian Culley to its Board of Directors as CEO

– USA, CA – BioTime, Inc. (NYSE:BTX | TASE:BTX), a clinical-stage biotechnology company focused on degenerative diseases, today announced that the Board of Directors has implemented a new leadership structure under which Brian Culley has been appointed as the Company’s Chief Executive Officer and as a member of its Board of Directors, effective September 17, 2018.…

Strauss Group appoints Giora Bardea as CEO

– ISRAEL, Petach Tikva – Strauss Group (TASE:STRS) today announced that former deputy CEO Giora Bardea has been appointed as President and CEO of the group.…